Gerhard Walzl
- Bifunctional T cells allow for discrimination between latent and active tuberculosisBy Barbara Kalsdorf, Paulin Essone, Novel N. Chegou, André Loxton, Daleen Kriel, Volkmar Schöllhorn, Martin Ernst, Christoph Lange and Gerhard WalzlBarbara KalsdorfPaulin Essone1Division of Molecular Biology and Human Genetics, University of Stellenbosch, Tygerberg, South AfricaNovel N. Chegou1Division of Molecular Biology and Human Genetics, University of Stellenbosch, Tygerberg, South AfricaAndré Loxton1Division of Molecular Biology and Human Genetics, University of Stellenbosch, Tygerberg, South AfricaDaleen Kriel1Division of Molecular Biology and Human Genetics, University of Stellenbosch, Tygerberg, South AfricaVolkmar Schöllhorn3AID Autoimmun Diagnostika GmbH, Strassberg, GermanyMartin Ernst4Immune Cell-Analytics, Research Center Borstel, Borstel, GermanyChristoph Lange2Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, GermanyGerhard Walzl1Division of Molecular Biology and Human Genetics, University of Stellenbosch, Tygerberg, South Africa
- Beyond the IFN-γ horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosisBy Novel N. Chegou, Jan Heyckendorf, Gerhard Walzl, Christoph Lange and Morten RuhwaldNovel N. Chegou1DST/NRF Centre of Excellence for Biomedical Tuberculosis Research and MRC Centre for Molecular and Cellular Biology, Division of Molecular Biology and Human Genetics, Dept of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South AfricaJan Heyckendorf2Clinical Infectious Diseases, German Center for Infection Research (DZIF) Tuberculosis Unit, Research Center Borstel, BorstelGerhard Walzl1DST/NRF Centre of Excellence for Biomedical Tuberculosis Research and MRC Centre for Molecular and Cellular Biology, Division of Molecular Biology and Human Genetics, Dept of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South AfricaChristoph Lange2Clinical Infectious Diseases, German Center for Infection Research (DZIF) Tuberculosis Unit, Research Center Borstel, Borstel3Center for Infection and Inflammation, University of Lübeck, Lübeck, Germany4Dept of Internal Medicine, University of Namibia School of Medicine, Windhoek, NamibiaMorten Ruhwald5Dept of Infectious Disease Immunology, Statens Serum Institut, Copenhagen6Clinical Research Centre, Copenhagen University Hospitals, Hvidovre, Denmark
- Rapid diagnosis of tuberculosis using ex vivo host biomarkers in sputumBy Martin O.C. Ota, Joseph F. Mendy, Simon Donkor, Toyin Togun, Mohammed Daramy, Marie P. Gomez, Novel N. Chegou, Abdou K. Sillah, Olumuyiwa Owolabi, Beate Kampmann, Gerhard Walzl and Jayne S. SutherlandMartin O.C. Ota1Vaccinology Theme, Medical Research Council Unit, Fajara, the GambiaJoseph F. Mendy1Vaccinology Theme, Medical Research Council Unit, Fajara, the GambiaSimon Donkor1Vaccinology Theme, Medical Research Council Unit, Fajara, the GambiaToyin Togun1Vaccinology Theme, Medical Research Council Unit, Fajara, the GambiaMohammed Daramy1Vaccinology Theme, Medical Research Council Unit, Fajara, the GambiaMarie P. Gomez1Vaccinology Theme, Medical Research Council Unit, Fajara, the GambiaNovel N. Chegou2DST/NRF Centre of Excellence for Biomedical Tuberculosis Research and MRC Centre for Molecular and Cellular Biology, Division of Molecular Biology and Human Genetics, Dept of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South AfricaAbdou K. Sillah1Vaccinology Theme, Medical Research Council Unit, Fajara, the GambiaOlumuyiwa Owolabi1Vaccinology Theme, Medical Research Council Unit, Fajara, the GambiaBeate Kampmann1Vaccinology Theme, Medical Research Council Unit, Fajara, the GambiaGerhard Walzl2DST/NRF Centre of Excellence for Biomedical Tuberculosis Research and MRC Centre for Molecular and Cellular Biology, Division of Molecular Biology and Human Genetics, Dept of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South AfricaJayne S. Sutherland1Vaccinology Theme, Medical Research Council Unit, Fajara, the Gambia
- Regulatory T-cells and high levels of FOXP3 mRNA lead to decreased immune responses during HIV-TB co-infectionBy Andre Loxton, Teri Roberts, Gillian Black and Gerhard WalzlAndre Loxton1Biomedical Sciences, University of Stellenbosch, Cape Town, Western Cape, South AfricaTeri Roberts1Biomedical Sciences, University of Stellenbosch, Cape Town, Western Cape, South AfricaGillian Black1Biomedical Sciences, University of Stellenbosch, Cape Town, Western Cape, South AfricaGerhard Walzl1Biomedical Sciences, University of Stellenbosch, Cape Town, Western Cape, South Africa
- Beyond the IFN-γ horizon: Biomarkers for immunodiagnosis of infection with M. tuberculosisBy Novel N. Chegou, Jan Heyckendorf, Gerhard Walzl, Christoph Lange and Morten RuhwaldArticle | Published in 2013 in European Respiratory JournalNovel N. Chegou*DST/NRF Centre of Excellence for Biomedical Tuberculosis Research and MRC Centre for Molecular and Cellular Biology, Division of Molecular Biology and Human Genetics, Dept of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg 7505, South AfricaJan Heyckendorf#Clinical Infectious Diseases, German Center for Infection Research (DZIF) Tuberculosis Unit, Research Center Borstel, Parkallee 1-40, 23845 Borstel, GermanyGerhard Walzl*DST/NRF Centre of Excellence for Biomedical Tuberculosis Research and MRC Centre for Molecular and Cellular Biology, Division of Molecular Biology and Human Genetics, Dept of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg 7505, South AfricaChristoph Lange#Clinical Infectious Diseases, German Center for Infection Research (DZIF) Tuberculosis Unit, Research Center Borstel, Parkallee 1-40, 23845 Borstel, Germany¶Center for Infection and Inflammation, University of Lübeck, Germany+Dept of Internal Medicine, University of Namibia School of Medicine, Windhoek, NamibiaMorten Ruhwald§Dept of Infectious Disease Immunology, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen S, DenmarkfClinical Research Centre, Copenhagen University Hospitals, Hvidovre. Kettegaard Alle 30, 2650 Hvidovre, Denmark
- Rapid diagnosis of tuberculosis using ex vivo host biomarkers in sputumBy Martin O.C. Ota, Joseph F. Mendy, Simon Donkor, Toyin Togun, Mohammed Daramy, Marie P. Gomez, Novel N. Chegou, Abdou K. Sillah, Olumuyiwa Owolabi, Beate Kampmann, Gerhard Walzl and Jayne S. SutherlandArticle | Published in 2014 in European Respiratory JournalMartin O.C. Ota1Vaccinology Theme, Medical Research Council Unit, Fajara, the Gambia,Joseph F. Mendy1Vaccinology Theme, Medical Research Council Unit, Fajara, the Gambia,Simon Donkor1Vaccinology Theme, Medical Research Council Unit, Fajara, the Gambia,Toyin Togun1Vaccinology Theme, Medical Research Council Unit, Fajara, the Gambia,Mohammed Daramy1Vaccinology Theme, Medical Research Council Unit, Fajara, the Gambia,Marie P. Gomez1Vaccinology Theme, Medical Research Council Unit, Fajara, the Gambia,Novel N. Chegou2DST/NRF Centre of Excellence for Biomedical Tuberculosis Research and MRC Centre for Molecular and Cellular Biology, Division of Molecular Biology and Human Genetics, Dept of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa,Abdou K. Sillah1Vaccinology Theme, Medical Research Council Unit, Fajara, the Gambia,Olumuyiwa Owolabi1Vaccinology Theme, Medical Research Council Unit, Fajara, the Gambia,Beate Kampmann1Vaccinology Theme, Medical Research Council Unit, Fajara, the Gambia,Gerhard Walzl2DST/NRF Centre of Excellence for Biomedical Tuberculosis Research and MRC Centre for Molecular and Cellular Biology, Division of Molecular Biology and Human Genetics, Dept of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa,Jayne S. Sutherland1Vaccinology Theme, Medical Research Council Unit, Fajara, the Gambia,
- QuantiFERON-TB performance enhanced by novel Mycobacterium tuberculosis-specific antigensBy Monica Losi, Ashley J. Knights, Francesca Mariani, Alfonso M. Altieri, Gregorino Paone, Andre G. Loxton, Novel N. Chegou, John Kenneth, Mario G. Alma, Vittorio Colizzi, Gerhard Walzl, Cesare Saltini, Jeff Boyle and Massimo AmicosanteArticle | Published in 2015 in European Respiratory JournalMonica Losi1Dept of Biomedicine and Prevention, University of Rome “Tor Vergata”, Rome, ItalyAshley J. Knights2QIAGEN Sciences LLC, Germantown, MD, USAFrancesca Mariani3Institute of Cell Biology and Neurobiology, National Research Council, Rome, ItalyAlfonso M. Altieri4Broncopneumologia e Tisiologia, Azienda Ospedaliera San Camillo Forlanini, Rome, ItalyGregorino Paone5Dept of Cardiovascular, Respiratory, Nephrologic, Anesthesiologic and Geriatric Sciences, University of Rome “La Sapienza”, Rome, ItalyAndre G. Loxton6SA MRC Centre for TB Research, DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South AfricaNovel N. Chegou6SA MRC Centre for TB Research, DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South AfricaJohn Kenneth7Division of Infectious Diseases, St John's Research Institute, St John's National Academy of Health Sciences, Bangalore, IndiaMario G. Alma4Broncopneumologia e Tisiologia, Azienda Ospedaliera San Camillo Forlanini, Rome, ItalyVittorio Colizzi8Dept of Biology, University of Rome “Tor Vergata”, Rome, ItalyGerhard Walzl6SA MRC Centre for TB Research, DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South AfricaCesare Saltini1Dept of Biomedicine and Prevention, University of Rome “Tor Vergata”, Rome, ItalyJeff Boyle2QIAGEN Sciences LLC, Germantown, MD, USAMassimo Amicosante1Dept of Biomedicine and Prevention, University of Rome “Tor Vergata”, Rome, Italy
- QuantiFERON-TB performance enhanced by novel Mycobacterium tuberculosis-specific antigensBy Monica Losi, Ashley J. Knights, Francesca Mariani, Alfonso M. Altieri, Gregorino Paone, Andre G. Loxton, Novel N. Chegou, John Kenneth, Mario G. Alma, Vittorio Colizzi, Gerhard Walzl, Cesare Saltini, Jeff Boyle and Massimo AmicosanteMonica Losi1Dept of Biomedicine and Prevention, University of Rome “Tor Vergata”, Rome, ItalyAshley J. Knights2QIAGEN Sciences LLC, Germantown, MD, USAFrancesca Mariani3Institute of Cell Biology and Neurobiology, National Research Council, Rome, ItalyAlfonso M. Altieri4Broncopneumologia e Tisiologia, Azienda Ospedaliera San Camillo Forlanini, Rome, ItalyGregorino Paone5Dept of Cardiovascular, Respiratory, Nephrologic, Anesthesiologic and Geriatric Sciences, University of Rome “La Sapienza”, Rome, ItalyAndre G. Loxton6SA MRC Centre for TB Research, DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South AfricaNovel N. Chegou6SA MRC Centre for TB Research, DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South AfricaJohn Kenneth7Division of Infectious Diseases, St John's Research Institute, St John's National Academy of Health Sciences, Bangalore, IndiaMario G. Alma4Broncopneumologia e Tisiologia, Azienda Ospedaliera San Camillo Forlanini, Rome, ItalyVittorio Colizzi8Dept of Biology, University of Rome “Tor Vergata”, Rome, ItalyGerhard Walzl6SA MRC Centre for TB Research, DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South AfricaCesare Saltini1Dept of Biomedicine and Prevention, University of Rome “Tor Vergata”, Rome, ItalyJeff Boyle2QIAGEN Sciences LLC, Germantown, MD, USAMassimo Amicosante1Dept of Biomedicine and Prevention, University of Rome “Tor Vergata”, Rome, Italy
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.